Radnet (RDNT) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Radnet (RDNT) do?
Radnet Inc (RDNT) is a U.S.-listed company in Healthcare (Diagnostics & Research). What it does: Operates outpatient imaging centers that provide diagnostic scans including MRI, CT, and mammography. It is worth $5.48B on the market and sold $2.38B over the last year.
- Market cap
- $5.48B
- P/E ratio
- None (reported a loss)
- Annual sales
- $2.38B
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Brief updated
- Nov 17, 2026
Brands and businesses behind RDNT
- Lenox Hill Radiology: Operates outpatient imaging centers in the New York area, billing patients and insurers per diagnostic scan.
- New Jersey Imaging Network: Runs diagnostic imaging clinics across New Jersey, collecting fees from patients and healthcare plans for scans.
- DeepHealth: Develops artificial intelligence software for cancer screening and sells software subscriptions to clinical imaging centers.
- eRAD: Licenses clinical workflow systems and picture archiving software to hospitals and independent imaging facilities.
RDNT’s flags, in plain English
Each flag is a number from Radnet’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 17, 2026.
Still Climbing
Sales up 13.7% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Insiders Hold
Insiders own 10.5% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Debt Is Driving
Heavy debt, 194% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.
2 more risk notes open with the free trial. Try it free for 7 days.
Questions about RDNT
How big is Radnet?
Radnet’s market cap is $5.48B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $2.38B: what customers paid the company over the last year, before any costs.
What is RDNT’s P/E ratio?
RDNT has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with RDNT?
Reductions in Medicare and commercial insurance reimbursement rates directly lower revenue earned from diagnostic imaging procedures. That is one risk on Radnet’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Radnet’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. RDNT’s filings on SEC.gov. The Margin Monkey is research, not advice.
